The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-9-(2,4-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one ID: ALA4777859
PubChem CID: 162644152
Max Phase: Preclinical
Molecular Formula: C19H26F2N2O2
Molecular Weight: 352.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCN1CC2(CCN(CCc3ccc(F)cc3F)CC2)O[C@H](C)C1=O
Standard InChI: InChI=1S/C19H26F2N2O2/c1-3-23-13-19(25-14(2)18(23)24)7-10-22(11-8-19)9-6-15-4-5-16(20)12-17(15)21/h4-5,12,14H,3,6-11,13H2,1-2H3/t14-/m1/s1
Standard InChI Key: VXCBGIQXMBAMIY-CQSZACIVSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
6.2610 -5.1054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2569 -5.9226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9586 -6.3325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6690 -5.9297 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6731 -5.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9669 -4.6981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8536 -4.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8536 -5.1054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5589 -5.5099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2642 -4.2882 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5589 -3.8755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5589 -3.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1447 -3.8817 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3741 -6.3428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0844 -5.9388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7894 -6.3519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7818 -7.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4860 -7.5831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1973 -7.1790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2000 -6.3576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4951 -5.9482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1475 -5.5155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4387 -5.1087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4978 -5.1310 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.9029 -7.5912 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 1 1 0
1 10 1 0
10 11 1 0
11 12 1 1
7 13 2 0
4 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
8 22 1 0
22 23 1 0
21 24 1 0
19 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 352.43Molecular Weight (Monoisotopic): 352.1962AlogP: 2.61#Rotatable Bonds: 4Polar Surface Area: 32.78Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.15CX LogP: 2.25CX LogD: 1.43Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.84Np Likeness Score: -0.88
References 1. García M,Virgili M,Alonso M,Alegret C,Farran J,Fernández B,Bordas M,Pascual R,Burgueño J,Vidal-Torres A,Fernández de Henestrosa AR,Ayet E,Merlos M,Vela JM,Plata-Salamán CR,Almansa C. (2020) Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ Receptor Antagonist Clinical Candidate for the Treatment of Pain., 63 (24): [PMID:33064947 ] [10.1021/acs.jmedchem.0c01127 ]